Boehringer Ingelheim announced a voluntary recall of over 350,000 Combivent Respimat (ipratropium bromide, albuterol) 20mcg/100mcg inhalation sprays due to a defective delivery system.

The recalled Combivent Respimat spray was found to not spray properly, either emitting no spray or a short transient spray. The affected products have Lot #408267 with an expiration date of 11/30/2017. The 4g inhalers, containing 120 metered doses each, were distributed about three months ago on April 15, 2015.

RELATED: Stiolto Respimat Launched for COPD

Combivent Respimat is a propellant-free inhaler that combines an anticholinergic and a beta-2 agonist. It is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) when a second aerosol bronchodilator is needed.

For more information call (800) 542-6257 or visit